Vote Scores

Home / Companies / Vaxcyte, Inc. / 6 Jun 2024

Meeting · year to 30 June 2024475 filers reporting

Vaxcyte, Inc.: meeting of 6 Jun 2024

Votes reported on Form N-PX, item by item

475 Form N-PX filers reported votes at the Vaxcyte, Inc. meeting of 6 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 83.7% of reported votes for; 103 filers withheld from or voted against at least one nominee.

1,266 vote records from 219 filers. 11 of the 218 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

95.0% for0.0% against5.0% other5.0% against management219 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

750 vote records from 472 filers. 52 of the 457 filers that marked the item either way voted against management. 15 filers reported this item without a management mark.

85.8% for10.8% against3.4% other11.4% against management472 filers89.7% for9.8% against0.5% other9.9% against management141,302,404 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

422 vote records from 219 filers. 2 of the 218 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

99.1% for0.5% against0.5% other0.9% against management219 filers100.0% for0.0% against0.0% other0.0% against management58,677,845 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustForForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForAgainst *For
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonForForFor
PrincipalAbstain or withhold *ForFor
Capital Group and American FundsForAgainst *For
Pacific Life fundsForForFor
Global XForForFor
TransamericaForForFor
Federated HermesForForFor
AllianceBernsteinAbstain or withhold *ForFor
Hartford FundsForForFor
DWSForForFor
AllspringForForFor
MassMutualForForFor
Harbor FundsForForFor
VirtusForForFor
Janus HendersonForForFor
Neuberger BermanForForFor
Natixis and Loomis SaylesNo reportForNo report
Lord AbbettForForFor
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Vaxcyte, Inc. meeting?

475 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 52 of 457 voted against management (11.4%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Vaxcyte, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Vaxcyte, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Vaxcyte, Inc. with a meeting date within three days of 6 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.